Tag Archives: Patent

PositiveID Corporation Awarded U.S. Patent No. 8,133,451 for First-of-Its-Kind Detection System for Molecular …

by admin Posted on March 20, 2012

DELRAY BEACH, Fla., March 20, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID“) (OTCBB:PSID.OB – News), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense industry, … Continue reading →

Posted in Hpv | Tagged 8133451, awarded, Corporation, Detection, FirstofItsKind, Molecular, Patent, PositiveID, System, U.S. | Leave a comment

Patent Issued on Fusion-Protein Vaccine Technology

by admin Posted on February 29, 2012

NEWARK, Del., Feb. 29, 2012 /PRNewswire/ — iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering the use of iBio’s proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications. The invention comprises … Continue reading →

Posted in Hpv | Tagged FusionProtein, Issued, Patent, Technology, Vaccine | Leave a comment

U.S. Patent and Trademark Office Grants Patent to PositiveID Corporation for Portable Pathogen Detection

by admin Posted on December 6, 2011

DELRAY BEACH, Fla., Dec. 6, 2011 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID.OB – News), a developer of medical technologies and molecular diagnostic systems, announced today the U.S. Patent and Trademark Office has granted the Company Patent No. … Continue reading →

Posted in Hpv | Tagged Corporation, Detection, Grants, Office, Patent, Pathogen, Portable, PositiveID, Trademark, U.S. | Leave a comment

University of Rochester receives U.S. patent for HPV vaccine research

by admin Posted on November 23, 2011

The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market. The patent is for the creation of virus-like particles that mimic HPV 16, the type of HPV that causes … Continue reading →

Posted in Hpv | Tagged Patent, receives, Research, Rochester, U.S., University, Vaccine | Leave a comment

US patent awarded for Rochester’s pioneering HPV vaccine work

by admin Posted on November 23, 2011

Public release date: 22-Nov-2011[ | E-mail | Share ] Contact: Tom Rickeytom_rickey@urmc.rochester.edu585-275-7954University of Rochester Medical Center The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market. The patent is … Continue reading →

Posted in Hpv | Tagged awarded, Patent, pioneering, Rochester's, Vaccine, work | Leave a comment

Advaxis Announces Notice of Allowance of US Patent for ADXS-HPV Immunotherapy

by admin Posted on October 18, 2011

Related Quotes Symbol Price Change ADXS.OB 0.14 0.00 {“s” : “adxs.ob”,”k” : “a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00″,”o” : “”,”j” : “”} Press Release Source: Advaxis, Inc. On Tuesday October 18, 2011, 9:21 am EDT PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc., (OTCBB:ADXS.ob – News), a leader … Continue reading →

Posted in Hpv | Tagged Advaxis, ADXSHPV, Allowance, Announces, Immunotherapy, Notice, Patent | Leave a comment